Cannabis Use in Psychiatrie Patients.
S Chaudhury, S Sudarsanan, S K Salujha, K Srivastava
Medical journal, Armed Forces India February 2005 DOI: 10.1016/s0377-1237(05)80004-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Sample size | 471 |
| Population | Consecutive patients admitted to a tertiary care psychiatric center |
| Topics | Cannabis |
| Keywords | Cannabis dependence Psychiatric disorders |
| Key findings | Cannabis use was reported by 14.23% of 471 psychiatric inpatients; 1.49% met criteria for cannabis dependence and 0.64% showed symptoms characteristic of cannabis psychosis. Most users (83.58%) first used cannabis at ages 13-19 before entering service, and the most common reported reason was curiosity about its effects. |
Abstract
Cannabis abuse has been associated with psychiatric disorders. The pattern of cannabis use and incidence of cannabis dependence and cannabis psychosis among 471 consecutive patients admitted to a tertiary care psychiatric center was investigated. Cannabis use was reported by 67 (14.23%) patients of whom 42 (8.92%) were occasional users, 18 (3.82%) were classified as frequent users while 7 (1.49%) fulfilled criteria for cannabis dependence. 3 (0.64%) patients showed symptoms which were characteristic of cannabis psychosis. Among the 67 cannabis users, 56 (83.58%) had their first exposure to cannabis before entering service at 13-19 years of age. The remaining 14 (16.09%) began consuming cannabis 1-5 years after joining service. The reasons given for using cannabis were curiosity about its effects 32 (47.76%), peer pressure 17 (25.37%) or traditional use during festivals 18 (26.87%).
Comparable studies
Other observational and cohort studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population | 2009 | Case-control study | n = 454 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline | 2011 | Observational cohort | n = 1,923 |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... | 2005 | Observational cohort | n = 535 |
Citations in the library
Cited by 2
- Medical Cannabis sativa (Marijuana or drug type): Psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC) International Journal of Research and Innovation in Applied Science 2023
- Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma Industrial Psychiatry Journal October 1, 2021